nmb

Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched in April and was covered in Fast Company, Forbes, and the New York Times[1].

We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA sequencing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene.

If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: [email protected]

Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched 2 weeks ago and was covered in Fast Company, Forbes, and the New York Times[1]. We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA testing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene. If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: [email protected]

Color Genomics is democratizing access to high-quality genetic testing. Our first product, a breast and ovarian cancer risk test that's 1/10 the price of existing offerings, launched 2 weeks ago and was covered in Fast Company, Forbes, and the New York Times[1]. We're lucky to have a team that represents the best from of the worlds of software development and next-generation DNA testing, and a scientific advisory board that includes the scientist who discovered the BRCA1 gene. If you're an engineer who's willing to learn about biological problems, or have experience in next-generation sequencing, feel free to contact me directly: [email protected]